Shanghai Haixin Group Co Ltd B (900917) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shanghai Haixin Group Co Ltd B (900917) has a cash flow conversion efficiency ratio of 0.002x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($7.56 Million) by net assets ($4.15 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Shanghai Haixin Group Co Ltd B (900917) net asset quality to measure how much of total assets are equity-financed.
Shanghai Haixin Group Co Ltd B - Cash Flow Conversion Efficiency Trend (2015–2025)
This chart illustrates how Shanghai Haixin Group Co Ltd B's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Shanghai Haixin Group Co Ltd B (900917) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Shanghai Haixin Group Co Ltd B Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shanghai Haixin Group Co Ltd B ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Titan Minerals Ltd
AU:TTM
|
-0.013x |
|
Samick Thk
KO:004380
|
0.064x |
|
Garuda Maintenance Facility AeroAsia Tbk PT
JK:GMFI
|
-0.043x |
|
Mega Manunggal Property TBK PT
JK:MMLP
|
0.000x |
|
Bioxyne Ltd
AU:BXN
|
-0.064x |
|
Inseego Corp
NASDAQ:INSG
|
-0.067x |
|
Humanica Public Company Limited
BK:HUMAN
|
0.044x |
|
Microbot Medical Inc
NASDAQ:MBOT
|
-0.068x |
Annual Cash Flow Conversion Efficiency for Shanghai Haixin Group Co Ltd B (2015–2025)
The table below shows the annual cash flow conversion efficiency of Shanghai Haixin Group Co Ltd B from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Shanghai Haixin Group Co Ltd B.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $4.92 Billion | $117.69 Million | 0.024x | +38.99% |
| 2024-12-31 | $4.50 Billion | $77.52 Million | 0.017x | +298.48% |
| 2023-12-31 | $4.14 Billion | $-35.88 Million | -0.009x | -147.41% |
| 2022-12-31 | $4.02 Billion | $73.56 Million | 0.018x | -64.31% |
| 2021-12-31 | $4.28 Billion | $219.65 Million | 0.051x | +83.35% |
| 2020-12-31 | $4.38 Billion | $122.50 Million | 0.028x | +535.28% |
| 2019-12-31 | $4.05 Billion | $-26.02 Million | -0.006x | -141.97% |
| 2018-12-31 | $3.63 Billion | $55.50 Million | 0.015x | +354.26% |
| 2017-12-31 | $3.95 Billion | $13.31 Million | 0.003x | +173.71% |
| 2016-12-31 | $4.34 Billion | $-19.84 Million | -0.005x | +81.37% |
| 2015-12-31 | $4.80 Billion | $-117.88 Million | -0.025x | -- |
About Shanghai Haixin Group Co Ltd B
Shanghai Haixin Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in China and internationally. It is also involved in leasing of industrial park properties, financial investment and commodity trading, as well as production and sales of chemical drugs through its sales platform or local distributors; and research and development, production, and sales of plush fabrics… Read more